Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Corren

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Journal of Asthma and Allergy|March 25, 2024
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient TypesReynold Panettieri, Njira Lugogo, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
The effect of tezepelumab on hospitalizations and emergency department visits in patients with severe asthmaJonathan Corren, Stephanie Chen, Luke Callan, et al.
Chest|March 29, 2016
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil CountsJonathan Corren, Steven Weinstein, Lindsay Janka, et al.
Allergy and Asthma Proceedings|August 7, 2010
Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroidsSteven F Weinstein, Jonathan Corren, Kevin Murphy, et al.
Nutrition Journal|July 16, 2008
Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trialJonathan Corren, Marc Lemay, Yumei Lin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 27, 2004
Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadineCraig F LaForce, Jonathan Corren, William J Wheeler, et al.
Respiratory Medicine|January 1, 2013
Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthmaJonathan Corren, Lyndon E Mansfield, Tetyana Pertseva, et al.
Journal of Asthma and Allergy|January 20, 2021
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b StudyJonathan Corren, Martin Karpefors, Åsa Hellqvist, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 19, 2024
The combination of allergen immunotherapy and biologics for inhalant allergies: Exploring the synergyBianca Olivieri, Fatma Esra Günaydın, Jonathan Corren, et al.
Clinical Therapeutics|June 28, 2005
Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitisJonathan Corren, William Storms, Jonathan Bernstein, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Journal of Asthma and Allergy|March 25, 2024
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient TypesReynold Panettieri, Njira Lugogo, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
The effect of tezepelumab on hospitalizations and emergency department visits in patients with severe asthmaJonathan Corren, Stephanie Chen, Luke Callan, et al.
Chest|March 29, 2016
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil CountsJonathan Corren, Steven Weinstein, Lindsay Janka, et al.
Allergy and Asthma Proceedings|August 7, 2010
Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroidsSteven F Weinstein, Jonathan Corren, Kevin Murphy, et al.
Nutrition Journal|July 16, 2008
Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trialJonathan Corren, Marc Lemay, Yumei Lin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 27, 2004
Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadineCraig F LaForce, Jonathan Corren, William J Wheeler, et al.
Respiratory Medicine|January 1, 2013
Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthmaJonathan Corren, Lyndon E Mansfield, Tetyana Pertseva, et al.
Journal of Asthma and Allergy|January 20, 2021
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b StudyJonathan Corren, Martin Karpefors, Åsa Hellqvist, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 19, 2024
The combination of allergen immunotherapy and biologics for inhalant allergies: Exploring the synergyBianca Olivieri, Fatma Esra Günaydın, Jonathan Corren, et al.
Clinical Therapeutics|June 28, 2005
Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitisJonathan Corren, William Storms, Jonathan Bernstein, et al.
Pageof 15